HomeIoversolIoversol + Oral Cholecystographic Contrast Agents

Does Ioversol Interact with Oral Cholecystographic Contrast Agents?

Ioversol and Oral Cholecystographic Contrast Agents have a major drug interaction according to U.S. FDA drug labeling data. Renal toxicity reported in patients with liver impairment given oral cholecystographic agents followed by intravascular contrast agents. IOVERSOL administration should be postponed in patients recently receiving cholecystographic contrast. The mechanism involves null. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Ioversol Class
Radiographic Contrast Agent
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Ioversol and Oral Cholecystographic Contrast Agents occurs because null. Clinically, this means renal toxicity reported in patients with liver impairment given oral cholecystographic agents followed by intravascular contrast agents. ioversol administration should be postponed in patients recently receiving cholecystographic contrast. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Ioversol and your doctor is considering prescribing Oral Cholecystographic Contrast Agents (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Ioversol(Optiray 320)+💊 Oral Cholecystographic Contrast Agents(Contrased)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Radiographic Contrast Agent
Drug B class
Source
NLP:ioversol

What this means in plain English

Renal toxicity reported in patients with liver impairment given oral cholecystographic agents followed by intravascular contrast agents. IOVERSOL administration should be postponed in patients recently receiving cholecystographic contrast.

About Ioversol and Oral Cholecystographic Contrast Agents

Ioversol is a Radiographic Contrast Agent. Oral Cholecystographic Contrast Agents is also sold under the brand name Contrased. Ioversol is given by intra-arterial infusion. Ioversol additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"null"

📖 Source: NLP:ioversol

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Ioversol and Oral Cholecystographic Contrast Agents against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.